S Haghpanah Selected Research

Deferoxamine (Desferal)

2/2015

Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Haghpanah Research Topics

Disease

2	Iron Overload 12/2019 - 02/2015
1	Infections 01/2020
1	Hepatitis C 01/2020
1	Drug-Related Side Effects and Adverse Reactions 02/2015
1	Thalassemia 02/2015
1	beta-Thalassemia (Cooley's Anemia) 02/2015
1	Obesity 01/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2011
1	Iron Deficiencies 02/2011
1	Anemia 02/2011
1	Congenital Abnormalities (Deformity) 01/2009
1	Erectile Dysfunction 01/2009
1	Penile Induration (Peyronie's Disease) 01/2009
1	Pain (Aches) 01/2009

Drug/Important Bio-Agent (IBA)

2	IronIBA 01/2020 - 02/2015
1	Deferoxamine (Desferal)FDA LinkGeneric 02/2015
1	EnzymesIBA 02/2015
1	Ferritins (Ferritin)IBA 02/2015
1	DeferiproneIBA 02/2015
1	Deferasirox FDA Link 02/2015
1	Chelating AgentsIBA 02/2015
1	CreatinineIBA 02/2015
1	NitrogenIBA 02/2015
1	Urea (Carbamide)FDA LinkGeneric 02/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	LeptinIBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 02/2011
1	Verapamil (Calan)FDA LinkGeneric 01/2009
1	Pharmaceutical PreparationsIBA 01/2009

Therapy/Procedure

1	Blood Transfusion (Blood Transfusions) 12/2019
1	Therapeutics 02/2015
1	Aftercare (After-Treatment) 01/2009